Fresenius | Bruttoavancen På Salg



Gross Profit On Sales Lave om Dato
Akzo Nobel EUR 1.03B 57M 2024-12
Alcon AG USD 1.38B 14M 2024-12
AstraZeneca USD 12.17B 1.06B 2024-12
BASF EUR 3.83B 364M 2024-09
Bayer EUR 6.01B 1.13B 2024-12
Beiersdorf EUR 2.7B 366M 2024-12
DaVita Healthcare Partners USD 1.07B 42.4M 2024-12
Demant DKK 8.58B 4.32B 2024-12
E.ON EUR 4.42B 872M 2024-09
Essilor EUR 8.16B 3.95B 2024-12
Fresenius EUR 1.42B 52M 2024-12
Fresenius Medical Care EUR 1.27B 124.43M 2024-12
Getinge SEK 5.05B 1.5B 2024-12
Givaudan CHF 823M 575M 2024-06
GlaxoSmithKline GBP 5.56B 57M 2024-12
GN Store Nord DKK 2.67B 389M 2024-12
GRIFOLS EUR 766.49M 39.74M 2024-12
Hikma Pharmaceutical USD 756M 82M 2024-06
Lonza CHF 1.12B 276M 2024-06
Merck EUR 3.14B 89M 2024-09
Novartis USD 10.23B 294M 2024-12
Philips EUR 1.96B 43M 2024-12
Roche Holding CHF 11.69B 48M 2024-12
RWE EUR 1.12B 1.59B 2024-09
Sanofi EUR 10.07B 2.1B 2024-09
Smith & Nephew USD 2.07B 98M 2024-12



Fresenius Bruttoavancen På Salg - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Mar 2025.